Long-acting Injectable Containing Lopinavir Eliminates Reliance on Ritonavir Pharmacokinetic Enhancement.
Saved in:
| Title: | Long-acting Injectable Containing Lopinavir Eliminates Reliance on Ritonavir Pharmacokinetic Enhancement. |
|---|---|
| Authors: | Perazzolo S; Department of Pharmaceutics, University of Washington, Seattle, Washington, USA., Flexner CW; Divisions of Clinical Pharmacology and Infectious Diseases, Departments of Medicine, Pharmacology and Molecular Sciences, and International Health, Johns Hopkins University, Baltimore, Maryland, USA., Stephen ZR; Department of Pharmaceutics, University of Washington, Seattle, Washington, USA., Acosta EP; Division of Pediatric Infectious Diseases, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Bender Ignacio RA; Division of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Ho RJY; Department of Pharmaceutics, University of Washington, Seattle, Washington, USA.; Department of Bioengineering, University of Washington, Seattle, Washington, USA. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2025 Sep 15; Vol. 232 (3), pp. 607-611. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
